Atlas Trials

Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer

Clinical trial NCT03251612 · COMPLETED

Trial details

NCT number
NCT03251612
Sponsor
Vejle Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2017-09-22
Primary completion
2021-08-23
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.